BSFAFBSF Enterprise Plc

About BSF Enterprise Plc (BSFAF)

BSF Enterprise Plc (BSFAF) is a Biotechnology company headquartered in London, ENG, United Kingdom whose shares trade over-the-counter on the OTCQB tier.

BSF Enterprise PLC (BSF) is focused on unlocking the next generation of biotechnological solutions - using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes, as part of a radical transformation to deliver sustainable solutions across a variety of sectors. The Company owns 100% of 3D Bio-Tissues Ltd which produces cultivated meat and lab-grown skin, and 100% of Kerato Ltd which develops tissue engineered corneal replacement tissue for medical and research uses. In addition, the Company owns 100% of BSF HK for commercialisation of its technology in China and Asia, 100% of Cultivated Meat Technologies Ltd which develops a technology platform for manufacturing cultivated meat in a scalable and cost-competitive manner, and 100% of Lab-Grown Leather for further customer driven product of its skin technology.

Products and services

The Company undertakes investment in businesses in the biotechnology, food technology, innovative marketing and e-commerce sectors. The company completed its first acquisition in May 2022 of 3D Bio-Tissues Ltd which is involved in the development of tissue engineering, serum-free media, lab-grown meat, lab-grown leather and the human cornea.

BSFAF key facts

Ticker symbol

BSFAF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

London, ENG, United Kingdom

Country of incorporation

GB

Year of incorporation

2018

Employees

18

Estimated market cap

$7.21M (as of May 9, 2025)

Shares outstanding

123,649,437

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Audited

Fiscal year end

9/30

Latest filing

Annual Report (Sep 30, 2024)

BSF Enterprise Plc leadership

• Che Connon — CEO
• Graham Duncan — CFO
• Ricardo Gouveia — Chief Scientific Officer
• Geoffrey Baker — Company Secretary

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with B